EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Serious Adverse Drug Reactions to Antipsychotics in Minors with Multiple Disabilities: Preventability and Potential Cost Savings by Therapeutic Drug Monitoring

Stefanie Fekete, Tim Güntzel, Karin Egberts, Julia Geissler, Antje Neubert, Manfred Gerlach, Marcel Romanos, Regina Taurines

Pharmacopsychiatry · 01.01.2023 · 56 (01) · 32-39

DOI: 10.1055/a-1963-7631 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacopsychiatry, erschienen am 01.01.2023. Verfasst von Stefanie Fekete und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department Child and Adolescent Psychiatry, Psychosomatic and Psychotherapy, Center of Mental Health, University Hospital Wuerzburg, Wuerzburg, Germa…. Hauptthemen laut MEDLINE: Antipsychotic Agents, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: G-BA) - 01NVF16021, Fund of the Federal Joint Committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Children and adolescents with multiple disabilities and mental disorders (CAMD) are frequently treated with antipsychotic drugs. However, CAMD are particularly susceptible to serious adverse drug reactions (sADRs). This retrospective study examined the frequency of sADRs to antipsychotics in CAMD. Further, the potential preventability of these sADRs through therapeutic drug monitoring (TDM) and the potential socio-economic benefits of TDM were explored.

Methods

Routine clinical data of all patients treated at a specialized psychiatric clinic for CAMD between January 2017 and December 2018 were retrospectively examined. Data on the occurrence of sADRs (definition according to the European Medicines Agency), their causality with antipsychotics, as well as their preventability (Schumock criteria) were extracted from patient files. The prolongation of the hospital stay due to sADRs was calculated, and the cost savings were estimated if TDM had been applied. The data were based on a subsample of the KiDSafe project, supported by the Innovation Fund of the Joint Federal Committee, grant number 01NVF16021.

Results

One hundred two CAMD who were administered at least one antipsychotic drug during inpatient treatment were identified. Of these patients, 22 (21.6%) sADRs with a possible causal relationship with the antipsychotic treatment were documented. Eleven sADRs (50%) could potentially have been prevented through TDM. Mitigating sADRs through TDM likely would have prevented prolonged hospital stays and thus conferred considerable savings for health insurance companies.

Discussion

The routine implementation of TDM is urgently recommended for antipsychotic treatment in CAMD to increase drug therapy safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antipsychotic AgentsDrug-Related Side Effects and Adverse ReactionsChildAdolescentHumansDrug MonitoringRetrospective StudiesMinorsCost Savings

Substanzen

Antipsychotic Agents

Autor:innen und Institutionen

  • Department Child and Adolescent Psychiatry, Psychosomatic and Psychotherapy, Center of Mental Health, University Hospital Wuerzburg, Wuerzburg, Germany.
  • AGNP-Work group 'Child and Adolescent Psychopharmacology'.
  • AGNP-Work group Therapeutic Drug Monitoring.
  • Competence network for Therapeutic Drug Monitoring in child and adolescent psychiatry.
  • Department of Paediatrics and Adolescent Medicine, University Hospital Erlangen, Erlangen, Germany.

Förderung

  • G-BA) - 01NVF16021
  • Fund of the Federal Joint Committee

Zitieren

APA

Fekete, S., Güntzel, T., Egberts, K., Geissler, J., Neubert, A., Gerlach, M., Romanos, M., & Taurines, R. (2023). Serious Adverse Drug Reactions to Antipsychotics in Minors with Multiple Disabilities: Preventability and Potential Cost Savings by Therapeutic Drug Monitoring. Pharmacopsychiatry, 56(01), 32-39. https://doi.org/10.1055/a-1963-7631

Vancouver

Fekete S, Güntzel T, Egberts K, Geissler J, Neubert A, Gerlach M, et al. Serious Adverse Drug Reactions to Antipsychotics in Minors with Multiple Disabilities: Preventability and Potential Cost Savings by Therapeutic Drug Monitoring. Pharmacopsychiatry. 2023;56(01):32-39. doi:10.1055/a-1963-7631

BibTeX
@article{Fekete2023,
  author = {Fekete, Stefanie and Güntzel, Tim and Egberts, Karin and Geissler, Julia and Neubert, Antje and Gerlach, Manfred and Romanos, Marcel and Taurines, Regina},
  title = {Serious Adverse Drug Reactions to Antipsychotics in Minors with Multiple Disabilities: Preventability and Potential Cost Savings by Therapeutic Drug Monitoring},
  journal = {Pharmacopsychiatry},
  year = {2023},
  volume = {56},
  number = {01},
  pages = {32--39},
  doi = {10.1055/a-1963-7631}
}
Kostenlos starten →